Human leukocyte antigen alleles associated with inhibitor development in severe hemophilia A: analysis of the “My Life, Our Future” hemophilia A cohort
Journal of Thrombosis and Haemostasis · 2026
DOI: 10.1016/j.jtha.2025.08.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Sara Contente und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. Electronic address: sara.contente@usuhs.edu. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Blood Coagulation Factor Inhibitors, Factor VIII, Hemophilia A. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Hemophilia Foundation, Sanofi.
Abstract (Originalsprache)
BACKGROUND: An earlier analysis of the "My Life, Our Future" Repository indicated the risk of individuals with severe hemophilia A (HA) developing neutralizing antifactor (F)VIII antibodies (inhibitors) was (1) higher in Black and Hispanic cohorts and (2) similar in intron-22 inversion mutations vs other large structural changes in the F8 gene. OBJECTIVES: This study determined whether specific human leukocyte antigen (HLA) alleles or haplotypes indicate either risk of or protection from inhibitor development in severe HA and if such associations correlate with race/ethnicity or F8 variant type. METHODS: HLA haplotypes were obtained from whole genome sequence data for 1841 subjects with severe HA and their racial/ethnic categories verified by principal component analysis. Pairwise and multivariable logistic regression analyses were performed for subcohorts of HLA alleles/haplotypes defined by HA mutation type and race/ethnicity. RESULTS: HLA-DRB1∗15:01, DQB1∗06:02, and DQA1∗01:02 and B∗07:02 were higher-risk alleles for the White/non-Hispanic cohort, while HLA-DRB∗14:01, DQB1∗05:03, DQB1∗03:01, B∗38:01, B∗44:02, and C∗05:01 were lower-risk alleles. HLA-B∗15:03 and B∗58:01 were higher-risk alleles for the Black/non-Hispanic cohort, while HLA-A∗33:03 was a lower-risk allele. Additional alleles were associated with inhibitor risk across the following cohorts: all (N = 1841), intron-22 inversion (n = 836), missense (n = 288), not-missense (n = 1553). No associations of HLA with inhibitor risk were seen for the Hispanic/White cohort. Analysis of subjects carrying both higher-risk and lower-risk alleles revealed combinations affecting the risks associated with individual alleles. CONCLUSION: Our results implicate both innate and adaptive immune mechanisms, possibly including multiallelic HLA-associated effects on FVIII processing/presentation or signaling pathways in the development of inhibitors vs peripheral tolerance to FVIII.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. Electronic address: sara.contente@usuhs.edu.
- Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
- Department of Medicine, University of Washington, Seattle, Washington, USA.
- Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA; Student Bioinformatics Initiative, Center for Military Precision Health, Uniformed Services University of the Health Sc…
- Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. Electronic address: kathleen.pratt@usuhs.edu.
Förderung
- NHLBI NIH HHS
- National Hemophilia Foundation
- Sanofi
- National Institutes of Health
- Uniformed Services University of the Health Sciences
- Hemophilia of Georgia
- National Heart Lung and Blood Institute Division of Intramural Research
- National Heart, Lung, and Blood Institute
Zitieren
APA
Contente, S., Ahmed, A. E., Konkle, B. A., Johnsen, J. M., Frank, A., & Pratt, K. P. (2026). Human leukocyte antigen alleles associated with inhibitor development in severe hemophilia A: analysis of the “My Life, Our Future” hemophilia A cohort. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.08.040
Vancouver
Contente S, Ahmed AE, Konkle BA, Johnsen JM, Frank A, Pratt KP. Human leukocyte antigen alleles associated with inhibitor development in severe hemophilia A: analysis of the “My Life, Our Future” hemophilia A cohort. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2025.08.040
BibTeX
@article{Contente2026,
author = {Contente, Sara and Ahmed, Anwar E and Konkle, Barbara A and Johnsen, Jill M and Frank, Andrew and Pratt, Kathleen P},
title = {Human leukocyte antigen alleles associated with inhibitor development in severe hemophilia A: analysis of the “My Life, Our Future” hemophilia A cohort},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
doi = {10.1016/j.jtha.2025.08.040}
}
EUVIMED